JAMA Neurology Author Interviews

High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

03.25.2024 - By JAMA NetworkPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Interview with Anne Kerbrat, MD, PhD, author of High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS. Hosted by Cynthia E. Armand, MD. Related Content: High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS

More episodes from JAMA Neurology Author Interviews